← Back to Search

Initial Low dose for Stress

N/A
Waitlist Available
Led By Doug Delahanty, PhD
Research Sponsored by Kent State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria: Active Medical Personnel or First-Responders working during the COVID-19 Pandemic -
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 40 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a toolkit of 3 activities to help with psychological resilience in medical personnel and first responders.

Eligible Conditions
  • Stress

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~40 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 40 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Affective Experience
Patient Health Questionnaire - 4
Treatment Acceptability Questionnaire
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Initial Low doseActive Control1 Intervention
Participants will receive only one daily positive emotion prompt in the first seven days of the toolkit use.
Group II: Initial high doseActive Control1 Intervention
Participants will receive two daily positive emotion prompts in the first seven days of use.

Find a Location

Who is running the clinical trial?

Kent State UniversityLead Sponsor
43 Previous Clinical Trials
5,889 Total Patients Enrolled
Doug Delahanty, PhDPrincipal InvestigatorKent State University
John Gunstad, PhDPrincipal InvestigatorKent State University
1 Previous Clinical Trials
200 Total Patients Enrolled
~182 spots leftby Nov 2025